Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $610.13 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Pharma plc | $175.09 | 8 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $154.07 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $84.28 | 1 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $71.69 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $39.82 | 3 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $24.56 | 1 | $0 (2017) |
| ACADIA Pharmaceuticals Inc | $19.40 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $15.12 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $13.60 | 1 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $12.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $15.12 | 1 | GlaxoSmithKline, LLC. ($15.12) |
| 2020 | $42.39 | 3 | Merck Sharp & Dohme Corporation ($28.79) |
| 2019 | $132.44 | 2 | Janssen Pharmaceuticals, Inc ($121.41) |
| 2018 | $155.13 | 7 | Horizon Pharma plc ($155.13) |
| 2017 | $265.05 | 7 | AstraZeneca Pharmaceuticals LP ($84.28) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 06/15/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/25/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/18/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/26/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/20/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: RAYOS | ||||||
| 10/30/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: RAYOS | ||||||
| 10/09/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: RAYOS | ||||||
| 09/04/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: RAYOS | ||||||
| 07/17/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: RAYOS | ||||||
| 04/19/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | Cash or cash equivalent | $128.18 | General |
| Category: RAYOS | ||||||
| 04/10/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: RAYOS | ||||||
| 12/12/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $71.69 | General |
| 06/28/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $84.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/15/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/09/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: DIABETES | ||||||
| 02/13/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: PDP | ||||||
| 01/25/2017 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: RAYOS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 335 | 792 | $129,300 | $54,320 |
| 2022 | 26 | 629 | 1,474 | $256,820 | $107,153 |
| 2021 | 27 | 622 | 1,346 | $232,475 | $100,573 |
| 2020 | 24 | 738 | 1,449 | $244,400 | $98,710 |
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 22 | 106 | $10,600 | $7,574 | 71.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 24 | 112 | $16,800 | $7,502 | 44.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 17 | 79 | $11,850 | $5,527 | 46.6% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 18 | 74 | $15,225 | $4,888 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 56 | $8,400 | $3,981 | 47.4% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 24 | 101 | $17,725 | $3,715 | 21.0% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 20 | 31 | $7,750 | $3,317 | 42.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 31 | 36 | $9,900 | $3,280 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $3,625 | $2,428 | 67.0% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 13 | 14 | $4,200 | $2,092 | 49.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 15 | 21 | $5,775 | $2,084 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 18 | $4,500 | $1,804 | 40.1% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 13 | 13 | $2,050 | $1,566 | 76.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $2,850 | $1,367 | 48.0% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 13 | 31 | $3,100 | $1,140 | 36.8% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 21 | 34 | $3,400 | $1,113 | 32.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $950.00 | $678.87 | 71.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $600.00 | $264.24 | 44.0% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2022 | 38 | 238 | $24,800 | $17,975 | 72.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 193 | $30,100 | $13,037 | 43.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 35 | 172 | $25,800 | $10,318 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 95 | $14,250 | $6,958 | 48.8% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 18 | 106 | $31,800 | $5,469 | 17.2% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 21 | 63 | $20,475 | $4,842 | 23.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 44 | 55 | $15,125 | $4,704 | 31.1% |
About Dr. Sharad Soni, M.D
Dr. Sharad Soni, M.D is a Internal Medicine healthcare provider based in Ozone Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295701357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharad Soni, M.D has received a total of $610.13 in payments from pharmaceutical and medical device companies, with $15.12 received in 2021. These payments were reported across 20 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($610.13).
As a Medicare-enrolled provider, Soni has provided services to 2,324 Medicare beneficiaries, totaling 5,061 services with total Medicare billing of $360,756. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Ozone Park, NY
- Active Since 02/27/2006
- Last Updated 07/22/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295701357
Products in Payments
- RAYOS (Drug) $175.09
- INVOKANA (Drug) $154.07
- FARXIGA (Drug) $84.28
- JANUVIA (Drug) $39.82
- NUEDEXTA (Drug) $24.56
- NUPLAZID (Drug) $19.40
- TRELEGY ELLIPTA (Drug) $15.12
- ENTRESTO (Drug) $13.60
- SOLIQUA (Drug) $12.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ozone Park
Dr. Michael Avaricio, Md, MD
Internal Medicine — Payments: $43,403
Dr. Woosup Kim, Md, MD
Internal Medicine — Payments: $2,370
Dr. Lola Iskhakova, Md, MD
Internal Medicine — Payments: $2,336
Mohammed Siddique, Md, MD
Internal Medicine — Payments: $1,289
Mohammed Basith, M.d, M.D
Internal Medicine — Payments: $641.88
Luis Almonte, Md, MD
Internal Medicine — Payments: $599.36